- Home
- CRDF vs NAZ Comparison
CRDF vs NAZ Comparison
Compare CRDF & NAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- NAZ
- Stock Information
- Founded
- CRDF 1999
- NAZ 1992
- Country
- CRDF United States
- NAZ United States
- Employees
- CRDF N/A
- NAZ N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- NAZ Finance/Investors Services
- Sector
- CRDF Health Care
- NAZ Finance
- Exchange
- CRDF Nasdaq
- NAZ Nasdaq
- Market Cap
- CRDF 152.3M
- NAZ 139.1M
- IPO Year
- CRDF N/A
- NAZ N/A
- Fundamental
- Price
- CRDF $2.15
- NAZ $12.00
- Analyst Decision
- CRDF Strong Buy
- NAZ
- Analyst Count
- CRDF 4
- NAZ 0
- Target Price
- CRDF $10.63
- NAZ N/A
- AVG Volume (30 Days)
- CRDF 723.0K
- NAZ 18.3K
- Earning Date
- CRDF 11-06-2025
- NAZ 01-01-0001
- Dividend Yield
- CRDF N/A
- NAZ 3.69%
- EPS Growth
- CRDF N/A
- NAZ N/A
- EPS
- CRDF N/A
- NAZ N/A
- Revenue
- CRDF $501,000.00
- NAZ N/A
- Revenue This Year
- CRDF N/A
- NAZ N/A
- Revenue Next Year
- CRDF N/A
- NAZ N/A
- P/E Ratio
- CRDF N/A
- NAZ N/A
- Revenue Growth
- CRDF N/A
- NAZ N/A
- 52 Week Low
- CRDF $1.90
- NAZ $9.22
- 52 Week High
- CRDF $5.64
- NAZ $11.37
- Technical
- Relative Strength Index (RSI)
- CRDF 43.50
- NAZ 47.18
- Support Level
- CRDF $2.06
- NAZ $11.74
- Resistance Level
- CRDF $2.33
- NAZ $12.08
- Average True Range (ATR)
- CRDF 0.11
- NAZ 0.16
- MACD
- CRDF -0.01
- NAZ -0.01
- Stochastic Oscillator
- CRDF 25.00
- NAZ 34.15
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About NAZ Nuveen Arizona Quality Municipal Income Fund
Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. Its primary investment objective is to provide current income exempt from both regular federal income taxes and Arizona individual income taxes. The fund's secondary objective is to enhance the portfolio value relative to the Arizona municipal bond market through investments in tax-exempt Arizona Municipal Obligations that, in the opinion of the Fund's investment adviser, are underrated or undervalued or represent municipal market sectors that are undervalued.